| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
| 06/13/2013 | US20130150352 Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130150344 Heterocyclic compound |
| 06/13/2013 | US20130150341 Novel compounds |
| 06/13/2013 | US20130150339 Bicyclic Aryl and Heteroaryl Sodium Channel Inhibitors |
| 06/13/2013 | US20130150326 Autotaxin inhibitors and uses thereof |
| 06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | CA2855351A1 Novel pyrrole derivatives |
| 06/12/2013 | EP2602259A2 Salt of proline derivative, solvate thereof, and production method thereof |
| 06/12/2013 | EP2602258A1 N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 06/12/2013 | EP2602248A1 Novel pyrrole compounds |
| 06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| 06/12/2013 | EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 06/12/2013 | EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
| 06/12/2013 | EP2600866A1 Processes for preparing tubulysins |
| 06/12/2013 | EP2475657B1 5-alkinylthien-2-ylcarboxylic acids as inhibitors of flaviviridae viruses |
| 06/12/2013 | EP2178869B1 Indole compounds as an inhibitor of cellular necrosis |
| 06/12/2013 | CN1854135B Heteronuclear compound with dicyandiamide connection and its medicinal use |
| 06/12/2013 | CN103155268A Photoelectric conversion element, pigment for photoelectric conversion element and compound |
| 06/12/2013 | CN103153992A Heteroarylpiperidine and -piperazine derivatives as fungicides |
| 06/12/2013 | CN103153991A Synthesis for thiazolidinedione compounds |
| 06/12/2013 | CN103153978A Compounds and methods for the treatment or prevention of flaviviridae viral infections |
| 06/12/2013 | CN103153970A Oxazole And Thiazole Compounds As Ksp Inhibitors |
| 06/12/2013 | CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/12/2013 | CN103153965A Quinoxaline derivates |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| 06/12/2013 | CN103145702A Aminopyrimidines useful as kinase inhibitors |
| 06/12/2013 | CN103145701A Method for synthesizing thiacloprid active compound and co-producing carbon powder |
| 06/12/2013 | CN103145700A 2-(2-benzyl hydrazono)-4-(benzofuran-5-yl) thiazole and preparation method and application thereof |
| 06/12/2013 | CN103145699A Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv |
| 06/12/2013 | CN103145643A Aminothiazole compound dehydration and alkylation method |
| 06/12/2013 | CN102250079B 5-[2-(Benzylimino)thiazole-4-yl]benzofuranol ether and its application in preparation of pesticide |
| 06/12/2013 | CN101959515B Glucokinase activators |
| 06/12/2013 | CN101208311B Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/11/2013 | US8461154 Methods of utilizing arylpiperazine derivatives |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2581516C Quinazoline derivatives |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/06/2013 | WO2013082490A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | WO2013082345A1 Aryl dihydropyridinone and piperidinone as mgat2 inhibitors |
| 06/06/2013 | WO2013082324A1 Improved modulators of hec1 activity and methods therefor |
| 06/06/2013 | WO2013079586A1 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof |
| 06/06/2013 | WO2013079495A1 2-(phenyl or pyrid-3-yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | WO2013079452A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/06/2013 | WO2013079425A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | WO2013078973A1 Large particle diameter dasatinib and preparation and use thereof |
| 06/06/2013 | WO2013078771A1 Poly (adp-ribose) polymerase inhibitor |
| 06/06/2013 | WO2013043744A3 Tricyclic compounds useful as neurogenic and neuroprotective agents |
| 06/06/2013 | WO2013033037A3 Novel antiprion compounds |
| 06/06/2013 | WO2012074126A9 Bicyclic compound |
| 06/06/2013 | WO2011117034A3 Cosmetic or dermatological preparations with a content of one or more thiazole derivatives |
| 06/06/2013 | US20130144055 Benzene Sulfonamide Thiazole And Oxazole Compounds |
| 06/06/2013 | US20130143934 Agent for regeneration and/or protection of nerves |
| 06/06/2013 | US20130143927 Compounds that modulate intracellular calcium |
| 06/06/2013 | US20130143906 Substituted pyrimidinone-phenyl-pyrimidinyl compounds |
| 06/06/2013 | US20130143885 Chemical inducers of neurogenesis |
| 06/06/2013 | US20130143882 Heterocyclic compounds and their uses |
| 06/06/2013 | US20130143880 Positive allosteric modulators of mglur2 |
| 06/06/2013 | US20130143874 Fused ring pyridine compound |
| 06/06/2013 | US20130143871 4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/06/2013 | US20130143862 Certain amino-pyridazines, compositions thereof, and methods of their use |
| 06/06/2013 | US20130143841 Benzoheterocyclic anti-bacterial agents |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | CA2857689A1 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors |
| 06/06/2013 | CA2857441A1 Carboxamide-substituted heteroaryl-pyrazoles and their use |
| 06/06/2013 | CA2857405A1 Poly (adp-ribose) polymerase inhibitor |
| 06/06/2013 | CA2856839A1 Substituted anilines as ccr(4) antagonists |
| 06/06/2013 | CA2856769A1 Novel 2h-indazoles as ep2 receptor antagonists |
| 06/06/2013 | CA2850705A1 2- (phenyl or pyrid - 3 - yl) aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease |
| 06/06/2013 | CA2850700A1 New bicyclic dihydroisoquinoline-1-one derivatives |
| 06/05/2013 | EP2599837A1 Novel azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording and inkjet recording |
| 06/05/2013 | EP2599779A1 Dispiro 1,2,4-trioxolane antimalarials |
| 06/05/2013 | EP2598502A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations. |
| 06/05/2013 | EP2598501A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 06/05/2013 | EP2598498A1 Hetero-bicyclic derivatives as hcv inhibitors |
| 06/05/2013 | EP2598482A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 06/05/2013 | EP2598147A1 N-methylformamide solvate of dasatinib |
| 06/05/2013 | CN103130797A Triphenylamine line type materials modified by electron drawing group and preparation method and purpose thereof |
| 06/05/2013 | CN103130796A 3-tertiary butyl pyrazole amides compounds and application thereof |
| 06/05/2013 | CN103130795A Lurasidone HCl crystal A and purpose thereof |
| 06/05/2013 | CN103130794A Lurasidone HCl crystal A preparing methods |
| 06/05/2013 | CN103130793A 3-(1-aryl-piperidin-4-yl)-2-aryl-thiazole-4-ketone compound, preparation method thereof and use thereof |
| 06/05/2013 | CN103130792A 2-aminothiazoles compound |
| 06/05/2013 | CN103130791A Novel benzamides compound |
| 06/05/2013 | CN103130775A Indolinone derivatives serving as tyrosine kinase inhibitors |
| 06/05/2013 | CN103130737A Cyclohexane amine compound and application of cyclohexane amine compound as anti-schizophrenia medicine |
| 06/05/2013 | CN103130736A Structure and antibacterial activity of ethoxy benzo isothiazolone aromatic acid ester |
| 06/05/2013 | CN102250078B Use of 4-(benzofuran-5-yl)-2-benzyliminothiazole in preparation of herbicide |
| 06/05/2013 | CN102134234B Indazolyl urea compounds and preparation method and medicinal use thereof |
| 06/04/2013 | US8455658 Thiazole and thiadiazole compounds for inflammation and immune-related uses |
| 06/04/2013 | US8455653 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors |
| 06/04/2013 | US8455525 Selective androgen receptor modulators |
| 06/04/2013 | US8455521 Diaminoalkane aspartic protease inhibitors |
| 06/04/2013 | US8455520 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 06/04/2013 | US8455499 Alkyne antagonists of lysophosphatidic acid receptors |
| 06/04/2013 | US8455476 Azetidinyl diamides as monoacylglycerol lipase inhibitors |